Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update

Therapeutic Solutions International, Inc. (OTCMKTS:TSOIGet Free Report) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 218,700 shares, a drop of 24.6% from the May 15th total of 290,200 shares. Based on an average trading volume of 38,818,200 shares, the days-to-cover ratio is currently 0.0 days.

Therapeutic Solutions International Price Performance

Shares of TSOI remained flat at $0.00 during midday trading on Friday. The company’s stock had a trading volume of 4,382,044 shares, compared to its average volume of 22,174,063. Therapeutic Solutions International has a twelve month low of $0.00 and a twelve month high of $0.00.

Therapeutic Solutions International Company Profile

(Get Free Report)

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.

Further Reading

Receive News & Ratings for Therapeutic Solutions International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapeutic Solutions International and related companies with MarketBeat.com's FREE daily email newsletter.